chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 12/7/2021 is when I noticed the little red spots on my face. I did have an appt that day with my primary doctor but for another reason. I did not mention them to her and she did not see them because I was wearing makeup and a mask. Later in the day I noticed they were on my ears, arm, legs and stomach. The spots were under my skin, you could not feel them and they did not itch or burn. I am unsure if I called my primary on the 7th or 8th but they made me an appt for 12/10. They had me go for lab work before the appt. While I was at the appt I had had a bloody nose all day and it would not stop. My primary told me to go to ER. I waited there for 2 hours and eventually a nurse came out and told me a way to hold my nose a certain way and that made it stop after 30 mins., so we left. On the 12/13/2021 received the results of my lab work. He asked if I went to the ER Friday. I told him that I was there but left because my nose stopped bleeding. He told me I needed to go to ER right away because platelet count was only 1000. Normal 150,000-450,000. So I went back to ER and told they my dr. told me to come immediately and the reason. They put me an examine room, checked my blood and set me up for a platelet infusion. Then they admitted me and sent me upstairs. I was there for 4 days. The did several lab test, abdominal ultrasound. I was also hooked up to IV's several bottles of Immunoglobulin, saline. Before I left hospital they started me on an oral medication of dexamethasone 40mg. When all my labs were good they sent me home 12/16/2021. I took dexamethasone 40mg for one more day. Then on 12/18/2021 prednisone 80mg. Then on the 20th I dropped it down to 40mg. One of the doctors I saw in the hospital had me follow-up with him on 12/21/2021 to get me in right away. They did lab work right in the office and my platelets were still up and wanted me to come back and to check my platelets. I have gone very Monday since then and have gone back and forth between Dr. and the CNP. I slowed down on prednisone 10 mg at a time. On Jan 3, 2022 my platelets were back down to 17,000 and I had to go back up to 80mg of predispose. I know have had a neural reaction to prednisone and have to see a neurologist, I shake constantly and have trouble seeing.
6 days p/vax lt arm devel severe itchiness @ site, devel redness, swelling & hot to touch to most of area of upper arm;outer edge of area felt hard;
pt recv vax & mom states approx 2 1/2hr p/vax pt c/o abd pains, flu-like sx & diarrhea & then something funny happened in head lasted about 45min to 1hr & then states was fine & no problems since;
I really dont know if its connected or not but for the sake of science, Im reporting whats Im experiencing right now. Who knows, this will be useful someday if it will taken in consonant with other experiences.  Im experiencing a slight pain in my inner ears and Tinnitus.
no adverse event; patient received improperly stored dose of rotateq; This spontaneous report was received from medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 29-APR-2020, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (therapy type: Digital Data Logger) (ROTATEQ) one dose for prophylaxis (strength, dose, route, lot/ batch number and expiry date were not reported (product storage error). The administered dose of the vaccine experienced a temperature excursion of 35 Fahrenheit for a time frame of 8 hours as recorded by a data logger. The vaccines had no previous temperature excursion. The patient experienced no adverse event. No product quality complaint was reported.  The outcome of product storage error and no adverse event was unknown.  This is one of the several reports from the same reporter.; Sender's Comments:  US-009507513-2005USA000681:
Runny nose, cough, post-nasal drainage, sneezing, itchy/watery eyes  Alka-seltzer plus  hot caramel tea with honey
Site pain; Back pain; Muscle ache; Migraines; Fever; Diarrhea; Nausea; Chills-temporary; The patient received third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD0809) via an unspecified route of administration in the right arm on 05Nov2021 at 12:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse (MVP) and migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included atenolol (TENORMIN), acetylsalicylic acid (ASPIRIN), paracetamol (TYLENOL), hydrocodone bitartrate, paracetamol (NORCO) and ketorolac tromethamine (SPRIX); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right arm on 26Mar2021 at 12:00 (at the age of 53-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 16Apr2021 at 12:00 (at the age of 53-years-old), as single dose for COVID-19 immunisation. The patient previously took promethazine hydrochloride (PHENERGAN), moxifloxacin hydrochloride (AVELOX) and butorphanol tartrate (STADOL) and experienced drug allergy. On 05Nov2021 at 20:00, the patient experienced site pain, back pain, muscle ache, migraines, fever, diarrhea, nausea and chills-temporary. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills-temporary was resolved on an unknown date in Nov2021; while that of events site pain, back pain, muscle ache, migraines, fever, diarrhea, nausea and  was resolving at the time of this report.
Pt recvd 2nd dose of vax on 25FEB93 & exp agitation, irritability, insomnia, visual distrubances, h/a, poor appetite, stomachache, lack of responsiveness; pt noted to run back & forth & give commands; pt hospitalized; EEG was neg;
Fever 102, + covid test 2 weeks ago, Body aches, chills, fatigue, headache, BOB, sweats, Soreness at injection site.
In 2015 I developed vulvar ulcerations (approximately 5), periorbital edema, and sensorineuroal hearing loss following vaccination with Td, Hep A, Menactra, Yellow fever and typhoid vaccines. This was previously submitted as a VAERS. I was treated with high dose steroids with partial restoration of my hearing. I  had these issues extensively worked up by GYN,  ENT and Rheumatology.   Since that time I have had spontaneous vulvar ulceration (typically 1 lesion) on 3 occasions over the past 5 years with no preceeding infections or clear triggers.   Approximately 36h after second COVID vaccination I began to develop vulvar ulcerations--currently have 4 -5 lesions. I also had body aches.
Patient was seen in the office a few weeks ago and was feeling well. Apparently, he received recent SHINGRIX vaccine and immediately started feeling worse after. Patient presented to hospital on 5/26 with fevers, malaise and myalgias. Serum creatinine was 4 on admission. Patient was started on broad spectrum antibiotics and developed worsening acidosis. He was eventually intubated for respiratory failure. He developed atrial fibrillation with rapid ventricular rate and was started on vasopressors for hypotension. Transferred to Regional hospital for acute renal failure and septic shock.
72 hours after the Flu shot, patient became too weak to stand. She was admitted to the hospital on Nov 2, 2021 - for further evaluation.  They gave her a new medication, starting  November 4th - Sinemet, 3 times per day.  On November 6th, she was transferred to a Skilled Nursing Facility for Physical Therapy. She is currently still at this evaluation.
Information has been received from a physician concerning a 15 month old male who, at 12 months of age, was vaccinated with a dose of varicella virus vaccine live. Concomitant vaccinations administered on that same day included a dose of MMR. The physician reported that the patient subsequently developed a severe case of shingles after being vaccinated with varicella virus vaccine live. Unspecified medical attention was sought and the patient was subsequently hospitalized. It was noted that lesions were collected from the patient and cultures (group A strep) were being grown to see if isolates were from the vaccine. At the time of this report, the outcome was unknown. Additional information has been requested.
10min p/vax while sleeping mom noticed bilat semiflexed arm shaking & unresponsive to name;pt noted by PNP, RN,SNP to be unresponsive to stimuli external & auditory for approx 3min;vitals stable throughout;pt awake w/rectal temp & BP
PROQUAD underwent a temperature excursion and was administered; This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 10-JUN-2021, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T036562 exp date 26-APR-2022) rHA (dose and route not reported) that underwent a temperature excursion. Previous temperature of excursion was 6°F to 14°F (14F) for 2 hours, 14°F to 46°F (45.5F) 1 hour and 30 minutes and 6°F t o14°F (14.4F) for 2 hours.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2106USA006475: US-009507513-2106USA006476: US-009507513-2106USA006477: US-009507513-2106USA006478: US-009507513-2106USA006479: US-009507513-2106USA006480: US-009507513-2106USA006481: US-009507513-2106USA006482: US-009507513-2106USA006483: US-009507513-2106USA006484: US-009507513-2106USA006485: US-009507513-2106USA006486: US-009507513-2106USA006487: US-009507513-2106USA006488: US-009507513-2106USA006489: US-009507513-2106USA006490: US-009507513-2106USA006491: US-009507513-2106USA006492: US-009507513-2106USA006493: US-009507513-2106USA006494: US-009507513-2106USA006495: US-009507513-2106USA006496: US-009507513-2106USA006497: US-009507513-2106USA006064: US-009507513-2106USA006458: US-009507513-2106USA006459: US-009507513-2106USA006460: US-009507513-2106USA006461: US-009507513-2106USA006462: US-009507513-2106USA006463: US-009507513-2106USA006464: US-009507513-2106USA006465: US-009507513-2106USA006466: US-009507513-2106USA006467: US-009507513-2106USA006468: US-009507513-2106USA006469: US-009507513-2106USA006470: US-009507513-2106USA006471: US-009507513-2106USA006472: US-009507513-2106USA006473: US-009507513-2106USA006474:
6/1 was shot. On 6/2 she noticed there was still pain but it was under the right axilla. There was redness starting 1 inch from injection, forming a line to axilla. Starting 20mg Prednisone for 5 days, starting today.
Left upper thigh with erythematous raised lesion that blanches; 3.5cm x 2.5cm
rash on injection site two days after fever and chills a day after headaches on the night of receiving vaccine and day after
Pt woke up in middle of night and with lt arm itching. Pt scratched it sore and hot (3 inches long, 1 inch wide area). Rt side on back of arm. Called doctor listed to notify of incident. Cold compress, Hydrocortisone cream, BENADRYL or ZYRTEC recommended for pt. Authorized 9-22-16 3:52 pm.
This spontaneous report as received from the receptionist refers to a patient of unknown age and gender who was administered the first dose of GARDASIL 0.5mL IM (lot # not reported) on 22-NOV-2011, and the second dose of GARDASIL 0.5mL IM (lot # not reported) on 19-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. Additional information has been requested.
-Right arm shoulder to elbow swelling and redness, no pain -Right arm small patch of blisters, no pain
She received her vaccine. The next few days, she was extremely tired and slept a lot. A couple days after the vaccine, she complained that her stomach hurt slightly. Days went by and the pain slowly got worse. She didn't feel like eating. Then on 2/8/21 in the middle of the night, she woke up in excruciating pstomach pain and her husband called ambulance. They rushed her to ER. The determined that her colon had ruptured near her stomach and they took her in for emergency colonoscopy. The surgery was a success, but a couple days after, she was weak and said she didn't want to fight any longer. They put her on hospice measures and she died 2/15/21. We feel that she was doing fine before the vaccine, and then all of a sudden this occurred. Seems to be too much of a coincidence. Finally taking the time to report it, in case there are others having colon and or stomach issues.
1) Small fluid-filled blisters on left leg, chest, back. 2) Starting to scab over after 5 days. 3) Symptom treatment.
Developed facial rash 6-8 hours after receiving H1N1 nasal vaccine. C/o erythema and pruritus. Pt put on prednisone 20 mg x 7 days; BENADRYL 25 mg x today.
Soreness at injection site. Fever, chills, joint pain and headache for about 24 hours.
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had previously received a COVID-19 Vaccine.  Concurrent medical conditions included Pre-diabetic and Drug allergy (Name of drug as was not reported). Concomitant products included ROSUVASTATIN from 15-Mar-2022 to 25-May-2022 for an unknown indication.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 25-May-2022 to 30-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-May-2022, SARS-CoV-2 test: negative (Negative) Tested negative. In June 2022, SARS-CoV-2 test: postive (Positive) Tested positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment.  The patient had completed the five day dosage, tested negative, then rebound symptoms began 3 or 4 days later (03-Jun-2022 04:00) and was tested positive.  Device Date: 03-Jun-2022 Company comment This spontaneous case reported by a patient, concerns a 67-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI of COVID-19 infection, on an unknown date after receiving the 4th dose of mRNA-1273 vaccine. Latency between vaccination and onset of the event could not be assessed. It was reported that the patient was treated with Nirmatrelvir, Ritonavir (Paxlovid) from 25-May-2022 for COVID-19 treatment for 5 days, was tested negative, then rebound symptoms began 3 or 4 days later (03-Jun-2022 04:00) and was tested positive. Details of the onset date, lab results and symptoms of this initial COVID-19 infection was not reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case reported by a patient, concerns a 67-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI of COVID-19 infection, on an unknown date after receiving the 4th dose of mRNA-1273 vaccine. Latency between vaccination and onset of the event could not be assessed. It was reported that the patient was treated with Nirmatrelvir, Ritonavir (Paxlovid) from 25-May-2022 for COVID-19 treatment for 5 days, was tested negative, then rebound symptoms began 3 or 4 days later (03-Jun-2022 04:00) and was tested positive. Details of the onset date, lab results and symptoms of this initial COVID-19 infection was not reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
extreme dizziness; really bad cramps; pain; This is a spontaneous report from a contactable consumer (patient). This 19-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient reported receiving her vaccine about 30 minutes prior to calling and mentioned that she experienced side effects she did not see in the fact sheet. The patient stated that during her 15-minute waiting period, she had "it" very bad as she had extreme dizziness and really bad cramps all at once. She stated she was back at home as of calling and mentioned that the pain was already gone, and the dizziness was not extreme anymore but still there; she inquired if this was common. The clinical outcome of extreme dizziness was not recovered, the outcome of really bad cramps was unknown, and the outcome of pain was recovered in 2021.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
feeling chills like it is going to a fever; feeling chills like it is going to a fever; her legs don't feel good; she wasn't feeling good at all; pain in her entire back; feels pain in her womb, like in her belly to lower abdomen area; she feels sometimes like she has to throw up; This is a spontaneous report from a contactable consumer. This 62-year-old female consumer (patient) reported for herself. A 62-year-old female patient received first dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Batch/lot number: Unknown, Expiry date: unknown), via an unspecified route on 21Aug2021, Saturday (age at vaccination: 62-year-old), as a single dose for covid-19 immunization. Medical history included diabetic, ongoing. It has been a long time since she was diagnosed. The patient concomitant medications were not reported. On 22Aug2021 (Sunday), patient was feeling chills like it is going to a fever and her legs don't feel good. She went to work like that, but she wasn't feeling good at all, and they said for her to go back home because she couldn't work like that. She was having pain in her entire back, feels pain in her womb, like in her belly to lower abdomen area and ever since she got it she has felt like she wanted to throw up but she hasn't done it, she only has the feeling of the symptom. herapeutic measures taken as a result of the events included Tylenol which she already took. The clinical outcome of the events was ongoing.  Follow-up attempts are completed. No further information is expected.
This is a spontaneous report from a contactable consumer (patient) reported for herself. A 34-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 03Apr2021 12:00 at 34 years old (Lot Number: ER8734) as single dose, for covid-19 immunisation. Medical history included Anemia, Depression, Chronic Dry Eye, penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for an unspecified indication, start and stop date were not reported; lifitegrast (XIIDRA) taken for an unspecified indication, start and stop date were not reported; escitalopram oxalate (LEXAPRO) taken for an unspecified indication, start and stop date were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took pseudoephedrine hydrochloride (SUDAFED) and experienced drug allergy. An hour after the vaccine on 03Apr2021, patient's fingers were red and swollen (like after exercise on a hot day) and she was itchy all over her body. No symptoms for almost 4 days--then she started feeling intermittently dizzy/lightheaded, feverish every night (chills and hot flashes) for the next 4 nights. She got a wracking cough and was short of breath (couldn't climb a single flight of stairs without needing to lie down for several minutes). She was also extremely exhausted-- slept 20 hours in a single day. After multiple telemedicine and in-person appointments, a trip to urgent care, and a chest x-ray and CT, she was diagnosed with pneumonia and treated with antibiotics, vitamin D, and two inhalers. She missed her period, had an elevated d-dimer, and her white blood cell count dropped from 7.0 Thousand u/L to 3.6. She was incapacitated for 2 weeks-- the sickest she had ever been in her life. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient performed Nasal Swab, negative on 11Apr2021. Therapeutic measures were taken for pneumonia. The outcome of the events was recovering.
awoke 4/26/2021 with double vision and slight dizziness; saw eye doctor 4/29 and was told I was experiencing palsy in my 3rd Cranial nerve; saw eye surgeon 5/4/2021 after my right eyelid went completely shut, he confirmed issues with 3rd Cranial nerve.  Now wearing eye patch on right eye to prevent double vision and I have follow up appointment on Tuesday, May 11.
Pt admitted on 08072021 with c/o fever. Pt had his 2-part series of COVID vaccination back in April. Fever has persisted over 101.   Pt is currently inpatient.
High Fever (102.7), Headaches, Body Aches. Unable to get out of bed x 3 days.  Called doctor. Received dose on Thursday. Called Doctor on Sunday. Was told to come in on Monday. Symptoms disappeared on Monday, so did not keep visit.
pt recv vax & failed to seroconvert w/a sigma ELISA test result of 0.03;MD reported 5 pt;
This spontaneous report was received from a physician via company representatives, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history or concomitant therapies were not reported. On 30-JUL-2014, the patient was vaccinated with an unspecified improperly stored dose of PNEUMOVAX 23 with a lot number J009689 and expiration date of 29-JAN-2015 (route of administration and anatomical location were not reported), which was stored at 59.9 Fahrenheit (F) Degrees (15.5 Celsius) (highest recorded temperature) for a total of 3864 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Rash at and around injection site 7 days after receiving. Faint arm pain also returned.  Headache and more than usual tiredness for 7 days after first dose